Ireland· IE-PA-EU/1/21/1550/001
Ponvory 2 mg+3 mg+4 mg+5 mg+6 mg+7 mg+8 mg+9 mg+10 mg film-coated tablets
A ponesimod product containing ponesimod, registered in Ireland by Laboratoires Juvise Pharmaceuticals. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ponesimod is registered in 2 of 19 countries.
Countries holding a registration under ATC L04AA50 (ponesimod), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Ponesimod · ATC L04AA50
2 / 19 countries
- Ireland
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Ponesimod
- Manufacturer
- Laboratoires Juvise Pharmaceuticals
- Country
- Ireland (IE)
- ATC code
- L04AA50
- ATC class
- Ponesimod
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1550/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ponesimod in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumPonvory 2 mgLaboratoires Juvise Pharmaceuticals
- SwitzerlandPonvory 2 mg, FilmtablettenMedius AG
- NorwayPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- United KingdomPonvory 10mg tabletsJuvise Pharmaceuticals
- CzechiaPONVORYLaboratoires Juvisé Pharmaceuticals, Villeurbanne
- SpainPONVORY 2, 3, 4, 5, 6, 7, 8, 9 y 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULALaboratoires Juvise Pharmaceuticals
- FinlandPonvoryLaboratoires Juvise Pharmaceuticals
- FrancePONVORY 2 mg + 3 mg + 4 mg + 5 mg + 6 mg + 7 mg + 8 mg + 9 mg + 10 mg, comprimé pelliculéLABORATOIRES JUVISE PHARMACEUTICALS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ponvory
- Liechtenstein · Ponvory
- Norway · Ponvory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd565078-e2b8-4959-8c83-fce16b4b7008 GET /v1/drugs/dd565078-e2b8-4959-8c83-fce16b4b7008?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L04AA",
"L04AA50"
],
"strength": null,
"pa_number": "EU/1/21/1550/001",
"substances": [
"Ponesimod"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "19/05/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ponesimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.